ID30118A - Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6 - Google Patents

Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6

Info

Publication number
ID30118A
ID30118A IDW00200101351A ID20011351A ID30118A ID 30118 A ID30118 A ID 30118A ID W00200101351 A IDW00200101351 A ID W00200101351A ID 20011351 A ID20011351 A ID 20011351A ID 30118 A ID30118 A ID 30118A
Authority
ID
Indonesia
Prior art keywords
daeza
adenosin
derives
making substituted
substituted
Prior art date
Application number
IDW00200101351A
Other languages
English (en)
Indonesian (id)
Inventor
Walter Rodriguez
James P Sherbine
Rick G Woodward
Adam W Sledeski
Matthew R Powers
Michael K O'brien
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of ID30118A publication Critical patent/ID30118A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW00200101351A 1998-12-21 1999-12-14 Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6 ID30118A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21

Publications (1)

Publication Number Publication Date
ID30118A true ID30118A (id) 2001-11-08

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101351A ID30118A (id) 1998-12-21 1999-12-14 Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6

Country Status (28)

Country Link
US (1) US6184382B1 (no)
EP (1) EP1175420B1 (no)
JP (1) JP2002533343A (no)
KR (1) KR20010087425A (no)
CN (1) CN1122667C (no)
AP (1) AP1336A (no)
AT (1) ATE235493T1 (no)
AU (1) AU774155B2 (no)
BG (1) BG105624A (no)
BR (1) BR9917088A (no)
CA (1) CA2357760A1 (no)
CZ (1) CZ20012283A3 (no)
DE (1) DE69906392T2 (no)
DK (1) DK1175420T3 (no)
EA (1) EA003645B1 (no)
EE (1) EE200100333A (no)
ES (1) ES2191489T3 (no)
HK (1) HK1041607A1 (no)
HU (1) HUP0105224A3 (no)
ID (1) ID30118A (no)
IL (1) IL143843A0 (no)
NO (1) NO319789B1 (no)
NZ (1) NZ512500A (no)
PL (1) PL349154A1 (no)
PT (1) PT1175420E (no)
SK (1) SK284767B6 (no)
WO (1) WO2000037469A2 (no)
YU (1) YU51401A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1063A (en) * 1996-12-11 2002-04-26 Aventis Pharmaceuticals Products Inc Preparation of [1s-[1a, 2b, 3b, 4a(S*)]-4-[7-[[1-3-chloro-2-thienyl) metthyl]propyl]amino]-3h-imidazo[4, 5-b]pyridin-3-YL]-N-ethyl-2,3-dihydroxycypentanecarboxamide.
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof

Also Published As

Publication number Publication date
EA003645B1 (ru) 2003-08-28
WO2000037469A3 (en) 2000-09-14
PL349154A1 (en) 2002-07-01
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
CN1122667C (zh) 2003-10-01
EP1175420A2 (en) 2002-01-30
ATE235493T1 (de) 2003-04-15
AU2181400A (en) 2000-07-12
JP2002533343A (ja) 2002-10-08
BR9917088A (pt) 2006-01-31
NO20013044D0 (no) 2001-06-19
HUP0105224A2 (en) 2002-06-29
KR20010087425A (ko) 2001-09-15
EE200100333A (et) 2002-08-15
US6184382B1 (en) 2001-02-06
HK1041607A1 (zh) 2002-07-12
BG105624A (en) 2002-01-31
ES2191489T3 (es) 2003-09-01
EP1175420B1 (en) 2003-03-26
DE69906392D1 (de) 2003-04-30
DE69906392T2 (de) 2004-02-05
IL143843A0 (en) 2002-04-21
AP1336A (en) 2004-11-30
NO20013044L (no) 2001-08-20
NZ512500A (en) 2003-01-31
EA200100697A1 (ru) 2001-12-24
DK1175420T3 (da) 2003-07-07
CA2357760A1 (en) 2000-06-29
HUP0105224A3 (en) 2003-01-28
WO2000037469B1 (en) 2000-11-02
SK284767B6 (sk) 2005-11-03
CN1333773A (zh) 2002-01-30
CZ20012283A3 (cs) 2001-10-17
PT1175420E (pt) 2003-08-29
AP2001002200A0 (en) 2001-09-30
SK9072001A3 (en) 2001-12-03
YU51401A (sh) 2003-12-31
NO319789B1 (no) 2005-09-12

Similar Documents

Publication Publication Date Title
ID26007A (id) Proses karbonilasi
ID27092A (id) Pembuatan ftalat anhidrida
ID24255A (id) Proses pembuatan dengan aroma tajam
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ID26990A (id) Metode pembuatan dimetilnaftalena
ID23963A (id) Proses pembuatan vinil asetat
ID22641A (id) Proses pembuatan e-kaprolaktam
ID23316A (id) Proses karbonilasi
ID27111A (id) Proses pembuatan epoksida
ID27494A (id) Proses pembuatan epoksida
ID25901A (id) Proses pembuatan 4-aminometil-pirolidin-3-on terlindung
ID20274A (id) Proses untuk memproduksi diamina
ID30503A (id) Proses yang diperbaiki untuk pembuatan heksametilenadiamina
ID20624A (id) Proses pembuatan 2'-flouro-5-metil-betha-l-rabinofuranosiluridin
ID24312A (id) Proses pembuatan hasil cetakan
ID27091A (id) Proses untuk produksi poliol poliester rantai panjang tanpa ditingkatkan
ID24971A (id) Proses baru pembuatan ketimin
ID22222A (id) Proses pembuatan tiazolidinadiona tersubstitusi
ID26016A (id) Proses untuk menghasilkan hinokitiol
ID22456A (id) Proses pembuatan diester-diester 2,3,5-trimetilhidrokuinon
ID27830A (id) Proses pembuatan neotame
ID21901A (id) Proses pembuatan garam-garam hidroksilamonium
ID27412A (id) Proses pembuatan urea
ID23155A (id) Proses pembuatan eprosartan
ID16364A (id) Proses pembuatan senyawa multidentat fosfit